Previous Next

2024-03-29

IL-41 in resistance to Kawasaki disease treatments

Hematology

In this study, researchers examined the importance of IL-41 in clinical parameters and treatment resistance in Kawasaki disease. A total of 93 children with the disease were included. Serum IL-41 levels were significantly increased in children resistant to Kawasaki disease treatments. Serum IL-41 levels were positively correlated with erythrocyte sedimentation rate, C-reactive protein and C-reactive protein/albumin ratio, but negatively correlated with albumin. Total number of fever days and neutrophil/lymphocyte ratio were independent predictors of resistance to intravenous immunoglobulin. 


Source(s) :
Yan Duan et al. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease. Int Immunopharmacol. 2023 Sep:122:110600. ;

Last press reviews


Virtual reality: a weapon against stigma?

By Ana Espino | Published on september 16, 2025 | 3 min read

TyG Index: a new ally against PCOS?

By Ana Espino | Published on september 18, 2025 | 3 min read...

How our cells neutralize toxic RNAs

By Lila Rouland | Published September 16, 2025 | 3 min read<br>